Article
Multicenter Noninferiority Evaluation of Hain GenoType MTBDR <i>plus</i> Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance
14 Apr 2016
Abstract excerpt
Less than 30% of multidrug-resistant tuberculosis (MDR-TB) patients are currently diagnosed, due to laboratory constraints. Molecular diagnostics enable rapid and simplified diagnosis. Newer-version line probe assays have not been evaluated against the WHO-endorsed Hain GenoType MTBDRplus (referred to as Hain version 1 [V1]) for the rapid detection of rifampin (RIF) and isoniazid (INH) resistance. A two-phase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
